US equities
|
SPCX
$150.21
▼-5.72%
META
$661.66
▼-5.14%
TSLA
$382.70
▼-0.98%
MU
$870.00
▼-4.78%
NVDA
$213.27
▼-3.92%
SNDK
$1,277.37
▼-7.32%
AMD
$511.69
▼-7.42%
AMZN
$252.20
▼-3.88%
SPCX
$150.21
▼-5.72%
META
$661.66
▼-5.14%
TSLA
$382.70
▼-0.98%
MU
$870.00
▼-4.78%
NVDA
$213.27
▼-3.92%
SNDK
$1,277.37
▼-7.32%
AMD
$511.69
▼-7.42%
AMZN
$252.20
▼-3.88%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Phase 3 Clinical Trial
Recent news which mentions Phase 3 Clinical Trial
UK Supports Psychedelic Research With Phase 3 Trial In Federal Health Sites
December 13, 2022
Tickers
AWKNF
Tags
Markets
Phase 3 Clinical Trial
Ketamine/Assisted Therapy
From
Benzinga
MAPS Completes Second Phase 3 Trial Of MDMA-Assisted Therapy For PTSD, Topline Data & New Drug Application Next
November 17, 2022
Tags
Cannabis
MDMA/assisted therapy
Benzinga
From
Benzinga
Compass Pathways Will Lead Two Concurrent Phase 3 Trials On Psilocybin-Assisted Therapy For Depression
October 12, 2022
Tickers
CMPS
Tags
Market News
Phase 3 Clinical Trial
Markets
From
Benzinga